healtheo360 presents: Exchange - Conversations With Professionals In Health


healtheo360 sits down with the leaders of biotech, medical device, and pharmaceutical companies to discuss their latest investments in their clinical pipeline as potential therapies and life-saving devices for patients with chronic conditions and their caregivers.  You can watch the full series here.

 

Lawrence Mayer | Celator Pharmaceuticals

Dave sits down with Lawrence Mayer of Celator Pharmaceuticals while at the JP Morgan Annual Health Conference. In this interview, they discuss Celator's innovative new anti-cancer therapy called CombiPlex, which carries nano-scale medicines directly to the tumor site.


 

 

 

Khalid Ishaque | Pixium Vision

Dave sits down with Khalid Ishaque from Pixium Vision while at the JP Morgan Annual Health Conference. In this interview, they discuss innovative new devices for vision restoration.

 

 

Hermann Lübbert | Biofrontera

Dave sits down with Hermann Lübbert from Biofrontera while at the JP Morgan Annual Health Conference. In this interview, they discuss Biofrontera's new topical medication for actinic keratosis, a non-melanoma form of skin cancer due to excessive sun exposure and sun damage.

 

 

Yuval Cohen | Corbus Pharmaceuticals

Dave sits down with Yuval Cohen from Corbus Pharmaceuticals just after the JP Morgan Annual Health Conference. In this interview, they discuss their innovative therapies for rare inflammatory diseases, such as Cystic Fibrosis, Systemic Sclerosis, and Dermatomyositis.

 

 

Spiro Rombotis | Cyclacel

Dave sits down with Spiro Rombotis from Cyclacel. In this interview, they discuss Cyclacel's development of oral therapies that target the various phases of cell cycle control for the treatment of cancer and other serious diseases.

 

 

Scott Jackson | Celator Pharmaceuticals

Dave sits down with Scott Jackson from Celator Pharmaceuticals at the JP Morgan Annual Health Conference. In this interview, they talk about VYXEOS and their CombiPlex proprietary platform to develop synergistic therapy combinations for patients with acute myeloid leukemia.

 

 

Patrick Lu | Sirnaomics

Dave sits down with Patrick Lu of Sirnaomics at the JP Morgan Annual Health Conference. In this interview, they discuss Sirnaomic's targeted therapeutics for critical human diseases, such as breast cancer, flu, cervical cancer, and colorectal cancer by using RNA interference technology.

 

 

Roslyn Brandon | Immunexpress

Dave sits down with Roslyn Brandon from Immunexpress at the JP Morgan Annual Health Conference. In this interview, they discuss the problems of diagnosing sepsis and their innovative solution with SeptiCyte.

 

Robert Clarke | Pulmatrix

Dave sits down with Robert Clarke from Pulmatrix at the JP Morgan Annual Health Conference. In this interview, they discuss Pulmatrix's development of new pulmonary therapeutics for medications that treat cystic fibrosis, COPD, and other conditions.

 

Rick Gonzalez | Navidea

Dave sits down with Rick Gonzalez of Navidea while at the JP Morgan Annual Health Conference. In this interview, they discuss Navidea's work in precision medicine for conditions affecting the immune system.

 

 

Michael Molyneaux | Sirnaomics

Dave sits down with Michael Molyneaux of Sirnaomics at the JP Morgan Annual Health Conference. In this interview, they discuss Sirnaomic's new therapies for skin scarless wound healing.

 

Martin Burns | Bruin Biometrics

Dave sits down with Martin Burns of Bruin Biometrics at the JP Morgan Annual Health Conference. In this interview, they discuss Bruin's new technology to detect pressure ulcers before they are visible to the human eye.

 

John Weinberg | Veloxis

Dave sits down with John Weinberg of Veloxis at the JP Morgan Annual Health Conference. In this interview, they discuss Veloxis' new developments surrounding medications for organ transplants.

 

George Yeh | Taiwan Liposome Company (TLC)

Dave sits down with George Yeh from TLC during the JP Morgan Annual Health Conference. In this video, they discuss new treatment technologies in oncology to precisely impact the tumor while minimizing the damage to healthy cells.

 

Roy Davis | Immunexpress

Dave sits down with Roy Davis from Immunexpress while at the JP Morgan Annual Health Conference. In this video, they discuss a new diagnostic test for detecting sepsis in patients.

Join the community!


You must be a member of healtheo360 in order to view this group

Register with Email Address

Already a member? Click here to login

healtheo360 believes strongly in user privacy.